Docetaxel Varifarma

PDFPrintEmail

Docetaxel Injection
Description
 
Product Name : DOCTETAXEL VARIFARMA
Generic Name : MITOTIC INHIITOR, CYTOTOXIC
Strength : 20 mg
Packing : 1's Vial + 1 vial solvent
Indications : Breast cancer, Lung cancer, non-small cell,  Head and neck cancer and Lung cancer
Dosage Guidelines : 100 mg/m2 (range 40-100 mg/m2) IV for one dose on day 1
The use of adjuvant TAC ( docetaxel, doxorubucin and cyclophosphamide) rather than FAC ( flurouracil, doxorubicin and cyclophamide ) for node positive early breast cancer patients is cost effective, despite the increased drug and toxicity treatment cost, and when primary G-csf prophylasis is given to all patients.

 

Featured Products